A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320
Townsend, William, Johnson, Rod J., Pottinger, Bryson T., Counsell, Nicholas, Smith, Paul, Chadwick, Humra, Evans, Katy, Wickham, Caroline, Rudin, Claudius E
Published in Leukemia & lymphoma (01.09.2016)
Published in Leukemia & lymphoma (01.09.2016)
Get full text
Journal Article